Warning: The NCBI web site requires JavaScript to function. more...
The cost-effectiveness of a school-based overweight program.
Brown HS 3rd, Pérez A, Li YP, Hoelscher DM, Kelder SH, Rivera R.
Int J Behav Nutr Phys Act. 2007 Oct 1;4:47.
Related citations
Economic analysis of a school-based obesity prevention program.
Wang LY, Yang Q, Lowry R, Wechsler H.
Obes Res. 2003 Nov;11(11):1313-24.
Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness.
Noyes K, Dick AW, Holloway RG; Parkinson Study Group.
Pharmacoeconomics. 2005;23(12):1257-70.
Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
Armstrong EP.
J Manag Care Pharm. 2010 Apr;16(3):217-30. Review.
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.
Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J, Jones J, Takeda A, Davidson P, Price A.
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL, Figgitt DP.
Pharmacoeconomics. 2004;22(6):389-411. Review.
Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Pinkerton SD, Holtgrave DR, Pinkerton HJ.
Arch Intern Med. 1997 Sep 22;157(17):1972-80.
Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults: a systematic review and economic evaluation.
Green C, Dinnes J, Takeda A, Shepherd J, Hartwell D, Cave C, Payne E, Cuthbertson BH.
Health Technol Assess. 2005 Mar;9(11):1-126, iii-iv.
Regional variation in the cost effectiveness of childhood hepatitis A immunization.
Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS.
Pediatr Infect Dis J. 2003 Oct;22(10):904-14.
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.
A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.
Karnon J, Czoski-Murray C, Smith K, Brand C, Chakravarthy U, Davis S, Bansback N, Beverley C, Bird A, Harding S, Chisholm I, Yang YC.
Health Technol Assess. 2008 Jun;12(27):iii-iv, ix-124.
Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children.
Kyle JW, Hammitt JK, Lim HW, Geller AC, Hall-Jordan LH, Maibach EW, De Fabo EC, Wagner MC.
Pediatrics. 2008 May;121(5):e1074-84.
Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L, Mkanje R, Grosskurth H, Mosha F, Picard J, Gavyole A, Todd J, Mayaud P, Swai R, Fransen L, Mabey D, Mills A, Hayes R.
Lancet. 1997 Dec 20-27;350(9094):1805-9.
The long-term cost effectiveness of treatments for benign prostatic hyperplasia.
DiSantostefano RL, Biddle AK, Lavelle JP.
Pharmacoeconomics. 2006;24(2):171-91. Review.
Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.
J Infect Dis. 2005 Nov 15;192(10):1720-6. Epub 2005 Oct 14.
Prevention of the epidemic increase in child risk of overweight in low-income schools: the El Paso coordinated approach to child health.
Coleman KJ, Tiller CL, Sanchez J, Heath EM, Sy O, Milliken G, Dzewaltowski DA.
Arch Pediatr Adolesc Med. 2005 Mar;159(3):217-24.
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.
An economic evaluation of the expanded food and nutrition education program.
Dollahite J, Kenkel D, Thompson CS.
J Nutr Educ Behav. 2008 May-Jun;40(3):134-43.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on